A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.
Commentary|Articles|March 27, 2026
CDC Opioid Guidelines at 10: Impact, Misuse, and Lessons: Michael Lynch, MD
Author(s)Sabrina McCrear, Michael Lynch, MD
Fact checked by: Maggie L. Shaw
A decade after the CDC opioid guidelines, Michael Lynch, MD, examines misapplication, fentanyl’s role, and evolving pain management strategies.
Advertisement
Advertisement
The CDC’s Clinical Practice Guidelines for Prescribing Opioids for Pain are
Related to this article
The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
A JAMA analysis of 2021-2023 death records found heat-related mortality varied sharply by occupation and industry among working-age US adults.
The trade group says CMS lacks authority to impose GLOBE, which is set to begin January 1.
Biomarker-driven care is advancing in mantle cell lymphoma, though cost and infrastructure limit access in community oncology, according to a review.
Stutsky explains why shifting therapy perceptions had more pharmacist touchpoints and longer time on therapy among patients with ATTR-CM.
CMS finalized Transparency in Coverage updates as a researcher warns ghost rates and missing inpatient data limit payer price files.
A scoping review of 15 studies found psoriasis prevalence markedly lower across 13 indigenous populations worldwide.
Advertisement
Advertisement